Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance

Journal of Diabetes and its Complications

Volumn 32, Issue 3, 2018, Pages 266-270

  Mazidi, Mohsen ^a,b   Kengne, Andre Pascal ^c   Katsiki, Niki ^d   Mikhailidis, Dimitri P ^e   Banach, Maciej ^f,g,h  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b International College   (China)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f MEDICAL UNIVERSITY OF LODZ   (Poland)

^g POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^h UNIVERSITY OF ZIELONA GÓRA   (Poland)

Author keywords

Insulin resistance; Lipid accumulation product; Triglycerides glucose index; Triglycerides:High density lipoprotein cholesterol ratio; Visceral adiposity index

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPID ACCUMULATION PRODUCT INDEX; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MIDDLE AGED; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROCEDURES; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDE GLUCOSE INDEX; VISCERAL ADIPOSITY INDEX; WAIST CIRCUMFERENCE; ANTHROPOMETRY; BLOOD; GLUCOSE BLOOD LEVEL; NUTRITION; OBESITY;

ADIPOSITY; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; CHOLESTEROL, HDL; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPID ACCUMULATION PRODUCT; MALE; MIDDLE AGED; NUTRITION SURVEYS; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES;

EID: 85041178562     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2017.10.007     Document Type: Article

References (57)

1. Mirmiran, P., Bahadoran, Z., Azizi, F., Lipid accumulation product is associated with insulin resistance, lipid peroxidation, and systemic inflammation in type 2 diabetic patients. Endocrinol Metab 29:4 (2014), 443–449.
2. Wakabayashi, I., Daimon, T., A strong association between lipid accumulation product and diabetes mellitus in Japanese women and men. J Atheroscler Thromb 21:3 (2014), 282–288.
3. Oh, J.Y., Sung, Y.A., Lee, H., The lipid accumulation product as a useful index for identifying abnormal glucose regulation in young Korean women. Diabet Med 30:4 (2013), 436–442.
4. Du, T., Yuan, G., Zhang, M., Zhou, X., Sun, X., Yu, X., Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol, 13, 2014, 146.
5. Kang, B., Yang, Y., Lee, E.Y., et al. Triglycerides/glucose index is a useful surrogate marker of insulin resistance among adolescents. Int J Obes(Lond) 41:5 (2017), 789–792.
6. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:7 (1985), 412–419.
7. Er, L.K., Wu, S., Chou, H.H., et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS One, 11(3), 2016, e0149731.
8. Abruzzese, G.A., Cerrrone, G.E., Gamez, J.M., Graffigna, M.N., Belli, S., Lioy, G., et al. Lipid accumulation product (LAP) and visceral adiposity index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm Metab Res 49:01 (2017), 23–29.
9. Quispe, R., Manalac, R.J., Faridi, K.F., et al. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: the very large database of Lipids-4 (VLDL-4) study. Atherosclerosis 242:1 (2015), 243–250.
10. Mazidi, M., Michos, E.D., Banach, M., The association of telomere length and serum 25-hydroxyvitamin D levels in US adults: the national health and nutrition examination survey. Arch Med Sci 13:1 (2017), 61–65.
11. Mazidi, M., Kengne, A.P., Sahebkar, A., Banach, M., Telomere length is associated with cardiometabolic factors in US adults. Angiology, 3319717712860, 2017.
12. Ford, E.S., Maynard, L.M., Li, C., Trends in mean waist circumference and abdominal obesity among US adults, 1999–2012. JAMA 312:11 (2014), 1151–1153.
13. National Center for Health Statistics CfDCaPNHaNESA. http://www.cdc.gov/nchs/nhanes.htm [f].
14. Musso, G., Gambino, R., Bo, S., et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with adult treatment panel III criteria in nonobese nondiabetic subjects. Diabetes Care 31:3 (2008), 562–568.
15. http://www.cdc.gov/NCHS/data/nhanes/nhanes_09_10/CRP_F_met.pdf. (Accessed 19 August 2013)
16. Simental-Mendia, L.E., Rodriguez-Moran, M., Guerrero-Romero, F., The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:4 (2008), 299–304.
17. Samouda, H., Dutour, A., Chaumoitre, K., Panuel, M., Dutour, O., Dadoun, F., VAT = TAAT-SAAT: innovative anthropometric model to predict visceral adipose tissue without resort to CT-scan or DXA. Obesity (Silver Spring) 21:1 (2013), E41–50.
18. Amato, M.C., Giordano, C., Galia, M., et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33:4 (2010), 920–922.
19. Onat, A., Avci, G.S., Barlan, M.M., Uyarel, H., Uzunlar, B., Sansoy, V., Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord 28:8 (2004), 1018–1025.
20. Mazidi, M., Kengne, A.P., Banach, M., Mineral and vitamins consumption is associated with longer telomeres among US adults. Pol Arch Med Wewn 127:2 (2017), 87–90, 10.20452/pamw.3927 [Epub 2017 Feb 2].
21. Mazidi, M., Vatanparast, H., Kengne, A.P., Impact of the dietary fatty acid intake on C-reactive protein levels in US adults. Medicine (Baltimore), 96(7), 2017, e5736, 10.1097/MD.0000000000005736.
22. Bland, J.M., Altman, D.G., Measuring agreement in method comparison studies. Stat Methods Med Res 8:2 (1999), 135–160.
23. Obuchowski, N.A., Receiver operating characteristic curves and their use in radiology. Radiology 229:1 (2003), 3–8.
24. Youden, W.J., Index for rating diagnostic tests. Cancer 3:1 (1950), 32–35.
25. Hajian-Tilaki, K., Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med 4:2 (2013), 627–635.
26. Nascimento-Ferreira, M.V., Rendo-Urteaga, T., Vilanova-Campelo, R.C., et al. The lipid accumulation product is a powerful tool to predict metabolic syndrome in undiagnosed Brazilian adults. Clin Nutr 36:6 (2017), 1693–1700, 10.1016/j.clnu.2016.12.020 [Epub 2016 Dec 28].
27. Rotter, I., Ryl, A., Szylinska, A., Pawlukowska, W., Lubkowska, A., Laszczynska, M., Lipid accumulation product (LAP) as an index of metabolic and hormonal disorders in aging men. Exp Clin Endocrinol Diabetes 125:3 (2017), 176–182.
28. Xia, C., Li, R., Zhang, S., et al. Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. Eur J Clin Nutr 66:9 (2012), 1035–1038.
29. Urbanova, M., Haluzik, M., The role of adipose tissue in pathogenesis of type 2 diabetes mellitus. Cesk Fysiol 64:2 (2015), 73–78.
30. Park, Y.M., Zhang, J., Steck, S.E., et al. Obesity mediates the association between Mediterranean diet consumption and insulin resistance and inflammation in US adults. J Nutr 147:4 (2017), 563–571.
31. Guerrero-Romero, F., Villalobos-Molina, R., Jiménez-Flores, J.R., et al. Fasting triglycerides and glucose index as a diagnostic test for insulin resistance in young adults. Arch Med Res 47:5 (2016), 382–387, 10.1016/j.arcmed.2016.08.012.
32. Zhang, M., Wang, B., Liu, Y., et al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: the rural Chinese cohort study. Cardiovasc Diabetol, 16(1), 2017, 30.
33. Brown, J.C., Harhay, M.O., Harhay, M.N., Anthropometrically-predicted visceral adipose tissue and mortality among men and women in the third national health and nutrition examination survey (NHANES III). Am J Hum Biol, 29(1), 2017.
34. Brown, J.C., Harhay, M.O., Harhay, M.N., Anthropometrically predicted visceral adipose tissue and blood-based biomarkers: a cross-sectional analysis. Eur J Nutr, 2016, 1–8.
35. Katsiki, N., Nikolic, D., Montalto, G., Banach, M., Mikhailidis, D.P., Rizzo, M., The role of fibrate treatment in dyslipidemia: an overview. Curr Pharm Des 19:17 (2013), 3124–3131.
36. Vaidean, G., Manczuk, M., Vansal, S., Visceral adiposity index in prediabetes and diabetes: the Polish Norwegian study (PONS). FASEB J 31:1 Supplement (2017), 643–649.
37. Wanderley Rocha, D.R., Jorge, A.R., Braulio, V.B., Arbex, A.K., Marcadenti, A., Visceral adiposity measurements, metabolic and inflammatory profile in obese patients with and without type 2 diabetes mellitus: a cross-sectional analysis. Curr Diabetes Rev 13:1 (2017), 11–18.
38. Verweij, L.M., Terwee, C.B., Proper, K.I., Hulshof, C.T., van Mechelen, W., Measurement error of waist circumference: gaps in knowledge. Public Health Nutr 16:2 (2013), 281–288.
39. Heymsfield, S.B., Peterson, C.M., Thomas, D.M., Heo, M., Schuna, J.M. Jr., Why are there race/ethnic differences in adult body mass index-adiposity relationships? A quantitative critical review. Obes Rev 17:3 (2016), 262–275.
40. Wulan, S.N., Westerterp, K.R., Plasqui, G., Ethnic differences in body composition and the associated metabolic profile: a comparative study between Asians and Caucasians. Maturitas 65:4 (2010), 315–319.
41. Nazare, J.A., Smith, J.D., Borel, A.L., et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: The international study of prediction of intra-abdominal adiposity and its relationship with cardiometabolic risk/intra-abdominal adiposity. Am J Clin Nutr 96:4 (2012), 714–726.
42. Haldar, S., Chia, S.C., Henry, C.J., Body composition in Asians and Caucasians: comparative analyses and influences on cardiometabolic outcomes. Adv Food Nutr Res 75 (2015), 97–154.
43. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 363(9403), 2004, 157–163.
44. Physical status: the use and interpretation of anthropometry. report of a WHO expert committee. World Health Organization technical report series, Vol. 854, 1995, 1–452.
45. Rahman, M., Berenson, A.B., Accuracy of current body mass index obesity classification for white, black, and Hispanic reproductive-age women. Obstet Gynecol 115:5 (2010), 982–988.
46. Wang, Z., Ma, J., Si, D., Optimal cut-off values and population means of waist circumference in different populations. Nutr Res Rev 23:2 (2010), 191–199.
47. Sulistyoningrum, D.C., Gasevic, D., Lear, S.A., Ho, J., Mente, A., Devlin, A.M., Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study. Cardiovasc Diabetol, 12, 2013, 170.
48. Mente, A., Razak, F., Blankenberg, S., et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 33:7 (2010), 1629–1634.
49. Gao, H., Salim, A., Lee, J., Tai, E.S., van Dam, R.M., Can body fat distribution, adiponectin levels and inflammation explain differences in insulin resistance between ethnic Chinese, Malays and Asian Indians?. Int J Obes (Lond) 36:8 (2012), 1086–1093.
50. Willey, J.Z., Rodriguez, C.J., Carlino, R.F., et al. Race-ethnic differences in the association between lipid profile components and risk of myocardial infarction: The Northern Manhattan study. Am Heart J 161:5 (2011), 886–892.
51. Alberti, K.G., Eckel, R.H., Grundy, S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:16 (2009), 1640–1645.
52. Mazidi, M., Rezaie, P., Covic, A., Malyszko, J., Rysz, J., Kengne, A.P., Banach, M., Telomere attrition, kidney function, and prevalent chronic kidney disease in the United States. Oncotarget 8:46 (2017), 80175–80181, 10.18632/oncotarget.20706 [eCollection 2017 Oct 6].
53. Mazidi, M., Shivappa, N., Wirth, M.D., Hebert, J.R., Vatanparast, H., Kengne, A.P., The association between dietary inflammatory properties and bone mineral density and risk of fracture in US adults. Eur J Clin Nutr 71:11 (2017), 1273–1277, 10.1038/ejcn.2017.133 [Epub 2017 Oct 11].
54. Mazidi, M., Kengne, A.P., Mikhailidis, D.P., Toth, P.P., Ray, K.K., Banach, M., Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans. Lipids Health Dis, 16(1), 2017, 192, 10.1186/s12944-017-0571-x.
55. Mazidi, M., Toth, P.P., Banach, M., C-reactive Protein Is Associated With Prevalence of the Metabolic Syndrome, Hypertension, and Diabetes Mellitus in US Adults. Angiology, 2017, 3319717729288, 10.1177/0003319717729288 [Epub ahead of print].
56. Mazidi, M., Gao, H.K., Kengne, A.P., Inflammatory Markers Are Positively Associated with Serum trans-Fatty Acids in an Adult American Population. J Nutr Metab, 2017, 2017, 3848201, 10.1155/2017/3848201 [Epub 2017 Jul 11].
57. Mazidi, M., Gao, H.K., Shivappa, N., Wirth, M.D., Hebert, J.R., Kengne, A.P., The relationship of plasma Trans fatty acids with dietary inflammatory index among US adults. Lipids Health Dis, 16(1), 2017, 147, 10.1186/s12944-017-0527-1.